EAM Global Investors »

Halozyme Therapeutics shares owned by EAM Global Investors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by EAM Global Investors from 13F filings

Historical chart of EAM Global Investors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by EAM Global Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by EAM Global Investors

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.3M 75k 57.24
2022-12-31 $2.1M 37k 56.90
2022-06-30 $2.5M 57k 43.99

More positions owned by EAM Global Investors

Qifu Technology Common Stock (QFIN)
Wix.com Common Stock (WIX)
TransAlta Corp Common Stock (TAC)
Energy Holding Corp Common Stock (TGLS)
Celestica Common Stock (CLS)
Carpenter Technology Corp Common Stock (CRS)
Suntx Capital Management Corp Common Stock (ROAD)
Q2 Holdings Common Stock (QTWO)
American Healthcare REIT Common Stock (AHR)
Curtiss-Wright Corp Common Stock (CW)
MakeMyTrip Common Stock (MMYT)
RadNet Common Stock (RDNT)
Jefferies Financial Group Common Stock (JEF)
FTAI Aviation Common Stock (FTAI)
Argan Common Stock (AGX)

View all positions for EAM Global Investors

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Bank of America Corporation
Alliancebernstein
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Invesco
Congress Asset Management
Dimensional Fund Advisors
Goldman Sachs Group
Northern Trust
Charles Schwab Investment Management

View all funds holding Halozyme Therapeutics